GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Morgan Stanley India Investment Fund, Inc. (NYSE:IIF) » Definitions » 3-Year Revenue Growth Rate

IIF (Morgan Stanley India Investment Fund,) 3-Year Revenue Growth Rate : -4.40% (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Morgan Stanley India Investment Fund, 3-Year Revenue Growth Rate?

Morgan Stanley India Investment Fund,'s Revenue per Share for the six months ended in Dec. 2024 was $0.83.

During the past 12 months, Morgan Stanley India Investment Fund,'s average Revenue per Share Growth Rate was 28.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 8 years, the highest 3-Year average Revenue per Share Growth Rate of Morgan Stanley India Investment Fund, was 60.70% per year. The lowest was -203.30% per year. And the median was -29.65% per year.


Competitive Comparison of Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate

For the Asset Management subindustry, Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate falls into.


;
;

Morgan Stanley India Investment Fund, 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Morgan Stanley India Investment Fund,  (NYSE:IIF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Morgan Stanley India Investment Fund, 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Morgan Stanley India Investment Fund,'s 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Morgan Stanley India Investment Fund, Business Description

Traded in Other Exchanges
N/A
Address
1585 Broadway, New York, NY, USA, 10036
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.
Executives
Michael J Key officer: Vice President 1633 BROADWAY, 29TH FLOOR, NEW YORK NY 10019
Eddie Arthur Grier other: Advisory Board Member 11700 PLAZA AMERICA DRIVE, SUITE 500, RESTON VA 20190
Frances Cashman other: Advisory Board Member MORGAN STANLEY INVESTMENT MANAGEMENT, 1633 BROADWAY 29TH FLOOR, NEW YORK NY 10019
Deidre Downes officer: Chief Compliance Officer 1633 BROADWAY, 29TH FLOOR, NEW YORK NY 10019
Amay Ashok Hattangadi officer: Portfolio Manager 522 5TH AVENUE, NEW YORK NY 10036
City Of London Investment Group Plc 10 percent owner 77 GRACECHURCH STREET, LONDON X0 EC3V0AS
Jakki L. Haussler director 221 EAST FOURTH STREET, CINCINNATI OH 45202
Nancy Everett director 1812 PARK AVE, RICHMOND VA 23220
Patricia A Maleski director C/O J P MORGAN INVESTMENT MANAGEMENT INC, 522 FIFTH AVENUE, NEW YORK NY 10036
City Of London Investment Management Co Ltd 10 percent owner 77 GRACECHURCH STREET, LONDON X0 EC3V0AS
Timothy J Knierim officer: CCO 100 MULBERRY STREET, NEWARK NJ 07102
Joseph C Benedetti officer: Vice President C/O INVESCO, 225 LIBERTY STREET, NEW YORK NY 10281
John H Gernon officer: Principle Executive Officer 522 5TH AVENUE, NEW YORK NY 10036
Ashutosh Sinha other: Portfolio Manager 522 FIFTH AVENUE 19TH FLOOR, NEW YORK NY 10036
Arthur Jason Lev director, officer: President and PEO 522 5TH AVENUE, NEW YORK NY 10036